Thomas E Dolmage1,2, Dmitry Rozenberg1,3, Nina Malek1, Rachael A Evans3,4, Roger S Goldstein1,2,3. 1. Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, Canada. 2. Respiratory Diagnostic and Evaluation Services, West Park Healthcare Centre, Toronto, Canada. 3. Department of Medicine, University of Toronto, Canada. 4. Department of Infection, Immunity and Inflammation, University of Leicester, United Kingdom.
Abstract
Background: For assessing the effects of interventions on exercise tolerance, the tolerable duration (tlimit) of a high-intensity constant-speed endurance test is recommended. The test intensity is determined by the test speed (stest) which should be individualized to target a tlimit of 3 to 15 minutes. We determined the accuracy of setting the stest to achieve a targeted tlimit of 3 to 15 minutes using the participant's easily measured and non-fatiguing usual (susual) and fast (sfast) walk speeds. Methods: Participants with COPD were asked to walk at their usual and fast walk speeds to establish their susual and sfast. This required that they walk for less than 1 minute. The individualized stest was calculated from a previously developed equation (0.57 x [sfast - susual]) + susual. Participants then completed a constant-speed endurance test, walking at this calculated stest to intolerance, to determine if the resultant tlimit occurred within 3 to 15 minutes. Results: Twenty-nine participants (forced expiratory volume in 1 second [FEV1] standard deviation [SD ]=43 [25] %predicted; FEV1 to forced vital capacity [FVC]ratio= 41 [13]%; susual = 57.3 [10.4] meters per minute (m·min-1 ); sfast = 71.7 [10.7] m·min-1) completed the study. During testing, 24 (83%) participants used supplemental oxygen and 16 (55%) used a walking aid. The derived stest was 65.6 [10.3] m·min-1 with the observed tlimit of 6.0 [5.0] minute. Twenty-four of 29 (83 %) endurance tests were within 3 to 15 minutes. Conclusion: Using the usual and fast walk speeds provides a simple, quick, inexpensive method for clinicians to set an acceptable endurance walk speed.
Background: For assessing the effects of interventions on exercise tolerance, the tolerable duration (tlimit) of a high-intensity constant-speed endurance test is recommended. The test intensity is determined by the test speed (stest) which should be individualized to target a tlimit of 3 to 15 minutes. We determined the accuracy of setting the stest to achieve a targeted tlimit of 3 to 15 minutes using the participant's easily measured and non-fatiguing usual (susual) and fast (sfast) walk speeds. Methods:Participants with COPD were asked to walk at their usual and fast walk speeds to establish their susual and sfast. This required that they walk for less than 1 minute. The individualized stest was calculated from a previously developed equation (0.57 x [sfast - susual]) + susual. Participants then completed a constant-speed endurance test, walking at this calculated stest to intolerance, to determine if the resultant tlimit occurred within 3 to 15 minutes. Results: Twenty-nine participants (forced expiratory volume in 1 second [FEV1] standard deviation [SD ]=43 [25] %predicted; FEV1 to forced vital capacity [FVC]ratio= 41 [13]%; susual = 57.3 [10.4] meters per minute (m·min-1 ); sfast = 71.7 [10.7] m·min-1) completed the study. During testing, 24 (83%) participants used supplemental oxygen and 16 (55%) used a walking aid. The derived stest was 65.6 [10.3] m·min-1 with the observed tlimit of 6.0 [5.0] minute. Twenty-four of 29 (83 %) endurance tests were within 3 to 15 minutes. Conclusion: Using the usual and fast walk speeds provides a simple, quick, inexpensive method for clinicians to set an acceptable endurance walk speed.
Entities:
Keywords:
evaluation of interventions; exercise tolerance; lung diseases; obstructive; walking
Authors: Rachael A Evans; Kylie Hill; Thomas E Dolmage; Maria Blouin; Sachi O'Hoski; Dina Brooks; Roger S Goldstein Journal: Chest Date: 2011-03-10 Impact factor: 9.410
Authors: Denis E O'Donnell; Shawn Aaron; Jean Bourbeau; Paul Hernandez; Darcy Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Roger Goldstein; Rick Hodder; Francois Maltais; Jeremy Road Journal: Can Respir J Date: 2003 May-Jun Impact factor: 2.409
Authors: T E Dolmage; T K Waddell; F Maltais; G H Guyatt; T R J Todd; S Keshavjee; S van Rooy; B Krip; P LeBlanc; R S Goldstein Journal: Eur Respir J Date: 2004-02 Impact factor: 16.671
Authors: Dmitry Rozenberg; Thomas E Dolmage; Rachael A Evans; Roger S Goldstein Journal: J Cardiopulm Rehabil Prev Date: 2014 Sep-Oct Impact factor: 2.081
Authors: Vishal Bansal; Kylie Hill; Thomas E Dolmage; Dina Brooks; Lynda J Woon; Roger S Goldstein Journal: Chest Date: 2008-02-08 Impact factor: 9.410